Proposed federal rule could reduce Medicare remote patient monitoring access

A proposed Centers for Medicare & Medicaid Services rule would halt Medicare reimbursement when providers use outside health technology companies to administer remote patient monitoring, paying clinicians only when the service is delivered by someone at the facility where they work, KFF Health News reported on Oct. 26, 2026. The proposal responds to 2024 and 2025 reports from the HHS Office of Inspector General that raised concerns about fraud, a lack of data collection, and patients not receiving treatment from the clinician who prescribed the device.

The exposure is concentrated. Caroline Pearson of the Peterson Center on Healthcare told KFF the rule would "virtually eliminate" or "dramatically reduce" remote monitoring for many Medicare patients, with rural communities among the hardest hit, because most rural facilities offering these programs rely on third-party vendors. The rule applies only to traditional Medicare, not Medicare Advantage, which covers more than half of participants, but sources told KFF that Medicare Advantage plans, Medicaid programs and private insurers could adopt the same change. States have earmarked at least $240 million of first-year funding from the five-year, $50 billion Rural Health Transformation Program for remote monitoring, according to an Alliance for Connected Care report cited by KFF.

The evidence cuts both ways. Advocates say monitoring helps patients manage chronic conditions and avoid emergency visits; the proposed rule says outside vendors may have little established relationship with patients and can fragment care. More than 230 vendors, health systems and advocacy groups signed an opposition letter as of Sept. 14, while Humana, Blue Cross Blue Shield Association and Sutter Health, which runs its own program, largely support the proposal. KFF describes the rule as proposed, not final, and its reporting does not quantify clinical outcomes either way.

The move: have finance model remote monitoring revenue under the proposed rule, split by traditional Medicare versus other payers, and identify which patients and programs depend on vendor-delivered services. Operations should assess what bringing monitoring in-house would require in staff and workflow. Compliance should audit current programs against the OIG findings now, including data collection and prescribing-clinician involvement, since vendors and experts alike told KFF the programs need tighter oversight. That work protects patients like those in rural areas regardless of how the final rule lands.

You are a revenue cycle and finance advisor to the executive team of [your organization], a [type of organization] that runs remote patient monitoring programs.

Context: KFF Health News reported on Oct. 26, 2026 that a proposed Centers for Medicare & Medicaid Services rule would halt Medicare reimbursement when providers use outside health technology companies to administer remote patient monitoring. Under the proposal, clinicians would be paid only when the service is delivered by someone at the facility where they work. The rule applies only to traditional Medicare, not Medicare Advantage. Sources told KFF that Medicare Advantage plans, Medicaid programs and private insurers could adopt the same change. The proposal responds to 2024 and 2025 HHS Office of Inspector General reports on fraud, a lack of data collection, and patients not receiving treatment from the clinician who prescribed the device. KFF Health News describes the rule as proposed, not final, and its reporting does not quantify clinical outcomes either way.

Task: Model our remote monitoring revenue under the proposed rule. Identify which programs, and which patient populations in aggregate, depend on vendor-delivered services. Use program-level and aggregate figures only.

Output: A one-page memo for the executive team with these sections: Summary; Revenue at risk, split by traditional Medicare versus other payers; Programs and populations affected, in aggregate; Scenarios if other payers follow; Open questions and items to verify; Next steps for finance, operations and compliance.

My inputs: [annual remote monitoring revenue], [share of that revenue from traditional Medicare], [list of programs, each marked vendor-delivered or in-house], [aggregate enrollment per program], [names of our monitoring vendors].

Guardrails: Use only the facts above and the slots I have filled. Cite KFF Health News by name for every fact drawn from it. Flag anything uncertain, assumed, or needing verification, including the final rule text. Do not request or include patient data. Nothing here is medical or legal advice. Label the memo as a draft for the team to check.